Cargando…

Relative persistence of AAV serotype 1 vector genomes in dystrophic muscle

The purpose of this study was to assess the behavior of pseudotyped recombinant adeno-associated virus type 1 (rAAV2/1) vector genomes in dystrophic skeletal muscle. A comparison was made between a therapeutic vector and a reporter vector by injecting the hindlimb in a mouse model of Limb Girdle Mus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pacak, Christina A, Conlon, Thomas, Mah, Cathryn S, Byrne, Barry J
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Short Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2572159/ https://www.ncbi.nlm.nih.gov/pubmed/18854054 http://dx.doi.org/10.1186/1479-0556-6-14

Ejemplares similares

Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice
por: Pacak, Christina A, et al.
Publicado: (2008)

Tissue specific promoters improve specificity of AAV9 mediated transgene expression following intra-vascular gene delivery in neonatal mice
por: Pacak, Christina A, et al.
Publicado: (2009)

Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes
por: Nass, Shelley A., et al.
Publicado: (2017)

Optimization of AAV vectors to target persistent viral reservoirs
por: Colón-Thillet, Rossana, et al.
Publicado: (2021)

A dystrophic muscle broadens the contribution and activation of immune cells reacting to rAAV gene transfer
por: Ferrand, M, et al.
Publicado: (2014)

Identification of AAV serotypes for lung gene therapy in human embryonic stem cell-derived lung organoids
por: Meyer-Berg, Helena, et al.
Publicado: (2020)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors
por: Ling, Chen, et al.
Publicado: (2016)

Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice
por: Falk, Darin J, et al.
Publicado: (2015)

Serotype-specific Binding Properties and Nanoparticle Characteristics Contribute to the Immunogenicity of rAAV1 Vectors
por: Ferrand, Maxime, et al.
Publicado: (2015)

AAV9-TAZ Gene Replacement Ameliorates Cardiac TMT Proteomic Profiles in a Mouse Model of Barth Syndrome
por: Suzuki-Hatano, Silveli, et al.
Publicado: (2019)

CRISPR/Cas9 as an antiviral against Orthopoxviruses using an AAV vector
por: Siegrist, Cathryn M., et al.
Publicado: (2020)

AAV capsid CD8+ T-cell epitopes are highly conserved across AAV serotypes
por: Hui, Daniel J, et al.
Publicado: (2015)

Dystrophic muscles get overexcited
por: Wells, William A.
Publicado: (2004)

Dystrophic calcification in the masseter muscle
por: Walulik, Agata, et al.
Publicado: (2023)

T Cell-Mediated Immune Responses to AAV and AAV Vectors
por: Ertl, Hildegund C. J.
Publicado: (2021)

Biodistribution of adeno-associated virus serotype 9 (AAV9) vector after intrathecal and intravenous delivery in mouse
por: Schuster, Daniel J., et al.
Publicado: (2014)

Development of optimized AAV3 serotype vectors: Mechanism of high-efficiency transduction of human liver cancer cells
por: Cheng, Binbin, et al.
Publicado: (2011)

Targeting Visceral Fat by Intraperitoneal Delivery of Novel AAV Serotype Vector Restricting Off-Target Transduction in Liver
por: Huang, Wei, et al.
Publicado: (2017)

Thermal Stability as a Determinant of AAV Serotype Identity
por: Bennett, Antonette, et al.
Publicado: (2017)

Various AAV Serotypes and Their Applications in Gene Therapy: An Overview
por: Issa, Shaza S., et al.
Publicado: (2023)

Accurate Quantification of AAV Vector Genomes by Quantitative PCR
por: Martinez-Fernandez de la Camara, Cristina, et al.
Publicado: (2021)

Adeno-associated Virus (AAV) Serotypes Have Distinctive Interactions with Domains of the Cellular AAV Receptor
por: Pillay, Sirika, et al.
Publicado: (2017)

Increased mtDNA Abundance and Improved Function in Human Barth Syndrome Patient Fibroblasts Following AAV-TAZ Gene Delivery
por: Suzuki-Hatano, Silveli, et al.
Publicado: (2019)

AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6
por: Denard, Jérôme, et al.
Publicado: (2018)

Increased calcium influx in dystrophic muscle
Publicado: (1991)

Congenital dystrophic medial rectus muscles
por: Murthy, Ramesh
Publicado: (2017)

Three-dimensional multipotent progenitor cell aggregates for expansion, osteogenic differentiation and “in vivo” tracing with AAV vector serotype 6
por: Ferreira, Joäo R., et al.
Publicado: (2012)

Improvement of the mdx mouse dystrophic phenotype by systemic in utero AAV8 delivery of a minidystrophin gene
por: Koppanati, Bhanu Munil, et al.
Publicado: (2010)

An acidic oligopeptide displayed on AAV2 improves axial muscle tropism after systemic delivery
por: Lee, Ni-Chung, et al.
Publicado: (2012)

Micro-dystrophin AAV Vectors Made by Transient Transfection and Herpesvirus System Are Equally Potent in Treating mdx Mouse Muscle Disease
por: Hakim, Chady H., et al.
Publicado: (2020)

Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65
por: Georgiadis, A, et al.
Publicado: (2016)

Preferred transduction with AAV8 and AAV9 via thalamic administration in the MPS IIIB model: A comparison of four rAAV serotypes
por: Gilkes, J.A., et al.
Publicado: (2015)

Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors
por: Wang, Qizhao, et al.
Publicado: (2016)

A cellular and molecular spatial atlas of dystrophic muscle
por: Stec, Michael J., et al.
Publicado: (2023)

Global Seroprevalence of Pre-existing Immunity Against AAV5 and Other AAV Serotypes in People with Hemophilia A
por: Klamroth, Robert, et al.
Publicado: (2022)

Serotype-dependent recombinant adeno-associated vector (AAV) infection of Epstein–Barr virus-positive B-cells, towards recombinant AAV-based therapy of focal EBV + lymphoproliferative disorders
por: Ahmadi, Elham, et al.
Publicado: (2021)

A case of dystrophic calcification in the masseter muscle
por: Kim, Heon-Young, et al.
Publicado: (2017)

Innate Immune Responses to AAV Vectors
por: Rogers, Geoffrey L., et al.
Publicado: (2011)

AAV Vectored Immunoprophylaxis for Filovirus Infections
por: Rghei, Amira D., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rudonh5vjqhupe8n9b8le7jt94